Spun out from the University of Oxford, Oxford Brain Diagnostics (OBD) is pioneering early detection of neurodegenerative conditions using their breakthrough Cortical Disarray Measurement (CDM®) technology.
CDM® analyses microscopic brain cellular structures directly from standard MRI scans, enabling clinicians and biopharmaceutical partners to predict, detect, track, and monitor Alzheimer's disease and Parkinson's disease years before macrostructural damage appears.
Visit Corporate Website ↗
CDM Insights™
Quantifies changes in grey matter microstructural integrity at cellular resolution directly from standard MRI scans.
Partnered with global pharma leaders including AbbVie & NeuroTherapia for targeted, efficient clinical trial endpoints.
Seamlessly integrates with hospital PACS networks to return automated diagnostic reports within 12 hours.
Further announcements regarding expanding investments in biotechnology, medical devices, and healthtech will follow.
Founded in 2011, iHealth is the group's consumer health company in Türkiye, built on a single principle: to value people's health. It brings globally established, clinically trusted over-the-counter (OTC) and food supplement brands to the Turkish market.
The portfolio spans immunity, digestive health and children's nutrition through brands such as Sambucol®, Pro-Probiotic® and Haliborange® — with Sambucol becoming the reference name for elderberry supplements in Türkiye.
Visit Corporate Website ↗
A portfolio built entirely around over-the-counter and food supplement categories, from immunity support to digestive health.
Sambucol®, the black elderberry range that has become the reference brand for elderberry supplements in Türkiye.
Haliborange® and Pro-Probiotic® extend the portfolio into children's vitamins and probiotic nutrition.
iHealth operates as the group's established consumer health platform, complementing the investment activities presented above.